Tryp Therapeutics (TRYP) | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Home
Companies
Tryp Therapeutics

BRIEF

published on 05/01/2024 at 21:23, 6 months 19 days ago

Tryp Therapeutics finalise son acquisition par Exopharm Limited

Transaction Boursière Bourse Des Valeurs Canadiennes Tryp Thérapeutique Exopharm Limitée Bourse Australienne Des Valeurs Mobilières
BRIEF

published on 05/01/2024 at 21:23, 6 months 19 days ago

Tryp Therapeutics Completes Acquisition by Exopharm Limited

Tryp Therapeutics Canadian Securities Exchange Exopharm Limited Stock Transaction Australian Securities Exchange
PRESS RELEASE

published on 05/01/2024 at 21:18, 6 months 19 days ago

Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement
Tryp Therapeutics, Inc. and Exopharm Limited announce completion of acquisition deal through court-approved plan of arrangement. Shareholders to receive 3.616 Exopharm Shares for each Tryp Share held

Shareholders Tryp Therapeutics Exopharm Limited Arrangement Agreement Acquisition Deal
BRIEF

published on 04/24/2024 at 12:05, 6 months 26 days ago

Tryp Therapeutics Gears Up for Merger Completion with Exopharm, Announces Trading Halt

Tryp Therapeutics Exopharm Limited Mergers And Acquisitions Stock Trading Halt ASX Listing
BRIEF

published on 04/24/2024 at 12:05, 6 months 26 days ago

Tryp Therapeutics se prépare à finaliser sa fusion avec Exopharm et annonce l'arrêt des négociations

Fusions Et Acquisitions Tryp Thérapeutique Exopharm Limitée Arrêt Des Opérations Boursières Inscription ASX
PRESS RELEASE

published on 04/24/2024 at 12:00, 6 months 26 days ago

Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt
Tryp Therapeutics, Inc. announces shareholder approval and completion of plan of arrangement with Exopharm Limited. Anticipates trading on ASX as Tryptamine Therapeutics Limited (ticker symbol TYP) in May 2024

Shareholder Approval Exopharm Limited Plan Of Arrangement Tryp Therapeutics Inc. ASX Trading
BRIEF

published on 03/12/2024 at 11:05, 8 months 8 days ago

Tryp Therapeutics Announces Overwhelming Shareholder Approval for Arrangement Agreement

Biotechnology Tryp Therapeutics Shareholder Approval Exopharm Limited Arrangement Agreement
BRIEF

published on 03/12/2024 at 11:05, 8 months 8 days ago

Tryp Therapeutics annonce l'approbation massive des actionnaires pour la convention d'arrangement

Biotechnologie Approbation Des Actionnaires Tryp Thérapeutique Accord D'arrangement Exopharm Limitée
PRESS RELEASE

published on 03/12/2024 at 11:00, 8 months 8 days ago

Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
Tryp Therapeutics announces securityholders' approval of Arrangement with Exopharm Limited CAN 163 765 991 at annual meeting. Closing expected in late March 2024

Tryp Therapeutics Exopharm Limited Securityholders Arrangement Clinical-stage Biotechnology
PRESS RELEASE

published on 02/08/2024 at 22:00, 9 months 12 days ago

Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting
Tryp Therapeutics, Inc. obtains interim court order for proposed arrangement with Exopharm Limited ACN 163 765 991. Meeting scheduled for March 8, 2024, in Toronto, Ontario, to vote on the arrangement resolution

Tryp Therapeutics Exopharm Limited Interim Court Order Arrangement Resolution Meeting

Accesswire

Published on 11/21/2024 at 09:00, 1 hour 1 minute ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 26 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 36 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 10 hours 1 minute ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 11 hours 1 minute ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 20 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 1 hour ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 1 hour 1 minute ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 1 hour 1 minute ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 46 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 3 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 54 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 41 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE